F. v. Cigna Health and Life Insurance

District Court, D. Utah·Decided August 19, 2025·No. 1:22-cv-00068·Unknown

Opinion

FOR THE DISTRICT OF UTAH

S.F. and E.F., MEMORANDUM DECISION Plaintiffs, AND ORDER v. CIGNA HEALTH AND LIFE INSURANCE Case No. 1:22-cv-68-HCN COMPANY and SLALOM LLC, HEALTHCARE BENEFIT PLAN, Howard C. Nielson, Jr. United States District Judge Defendants.

The Plaintiffs, S.F. and E.F., sue the Defendants, Cigna Health and Life Insurance Company and the Slalom LLC, Healthcare Benefit Plan, asserting two claims under ERISA (the Employee Retirement Income Security Act, 29 U.S.C. § 1001, et seq.): (1) a claim for payment of improperly denied benefits, and (2) a claim for violations of the Mental Health Parity and Addiction Equity Act. All parties move for summary judgment. For the following reasons, the court grants the Defendants’ motions in part and denies them in part, denies the Plaintiffs’ motion, and remands the case to Cigna for further consideration of the Plaintiffs’ claim for payment of improperly denied benefits. I. Cigna serves as the claims administrator for the Plan. See Dkt. No. 15 at 2 ¶ 2. S.F. was a participant in the Plan and E.F. was a beneficiary. See id. at 2 ¶ 3. Among other covered services, the Plan provides benefits for medically necessary mental-health services at residential treatment facilities. See AR 30, 33–34. To be deemed medically necessary under the Plan, such residential treatment must be (1) “required to diagnose or treat an illness, Injury, disease or its symptoms;” (2) “in accordance with generally accepted standards of medical practice;” (3) “clinically appropriate in terms of type, frequency, extent, site and duration;” (4) “not primarily for the convenience of the patient, Physician or other health care provider;” (5) “not more costly than an alternative service(s), medication(s) or supply(ies) that is at least as likely to produce equivalent therapeutic or diagnostic results with the same safety profile as to the prevention, evaluation, diagnosis or

treatment of [a] Sickness, Injury, condition, disease or its symptoms; and” (6) “rendered in the least intensive setting that is appropriate for the delivery of the services, supplies or medication.” AR 73. The Plan further provides that “[i]n determining whether health care services . . . are Medically Necessary,” Cigna “may rely on the clinical coverage policies” that it “maintain[s].” Id. Among these policies are Cigna’s “Medical Necessity Criteria” for “Residential Mental Health Treatment for Children and Adolescents,” which include both “Criteria for Admission” and “Criteria for Continued Stay.” AR 233–34. Six criteria must be satisfied for admission to residential treatment: (1) “All elements of Medical Necessity must be met” under the Plan; (2) “The child/adolescent has been diagnosed

with a moderate-to-severe mental health disorder, per the most recent version of the Diagnostic and Statistical Manual of Mental Disorders and evidence of significant distress/impairment”; (3) “This impairment in function is seen across multiple settings such as; school, home, work, and in the community, and clearly demonstrates the need for 24 hour psychiatric and nursing monitoring and intervention”; (4) “As a result of the interventions provided at this level of care, the symptoms and/or behaviors that led to the admission can be reasonably expected to show improvement such that the individual will be capable of returning to the community and to a less restrictive level of care”; (5) “The child/adolescent is able to function with age-appropriate independence, participate in structured activities in a group environment, and both the individual and family are willing to commit to active regular treatment participation”; and (6) “There is evidence that a less restrictive or intensive level of care is not likely to provide safe and effective treatment.” AR 233. To qualify for continued stay in residential treatment, an “individual [must] continue[] to

meet all elements of Medical Necessity” under the Plan, as well as at least one of the following criteria: (1) “The treatment provided is leading to measurable clinical improvements in the moderate-to-severe symptoms and/or behaviors that led to this admission and a progression toward discharge from the present level of care, but the individual is not sufficiently stabilized so that he/she can be safely and effectively treated at a less restrictive level of care”; (2) “If the treatment plan implemented is not leading to measurable clinical improvements the moderate-to- severe symptoms and/or behaviors that led to this admission and a progression toward discharge from the present level of care, there must be ongoing reassessment and modifications to the treatment plan that address specific barriers to achieving improvement, when clinically indicated”; or (3) “The individual has developed new symptoms and/or behaviors that require

this intensity of service for safe and effective treatment.” AR 234. And all three of the following criteria must be satisfied: (1) “The child/adolescent and family are involved to the best of their ability in the treatment and discharge planning process”; (2) “Continued stay is not primarily for the purpose of providing a safe and structured environment”; and (3) “Continued stay is not primarily due to a lack of external supports.” Id. Beginning in February 2018, Dr. Hower Kwon, a psychiatrist, diagnosed E.F. “with major depression, ADHD, . . . and substance dependence.” AR 769; see also AR 766. According to his general pediatrician, Dr. Kathy Risse, E.F. was admitted to an intensive care unit on September 28, 2019, “due to acute hypoxemic respiratory failure, ARDS, and myocarditis after” the police “found him in his car” “with vaping paraphernalia and various opiates.” AR 756. E.F.’s urine tested “positive for ethanol, benzodiazepines, amphetamines, cocaine, and THC,” and a “pediatric psychiatry team” determined “that his behavior leading up to the hospitalization was a suicide attempt.” AR 756–57. In October 2019, E.F. began receiving treatment for ADHD,

an unspecified depressive disorder, and cannabis use disorder at Open Sky Wilderness Therapy, an outdoor behavioral healthcare program. See AR 957–58. After his discharge from Open Sky on January 1, 2020, E.F. was placed at Catalyst Residential Treatment Center on January 3, 2020. See AR 1045. Catalyst developed a treatment plan to address E.F.’s diagnoses for major depressive disorder, cannabis use disorder, and ADHD. See id. On January 6, 2020, Cigna denied coverage under the Plan for E.F.’s treatment at Catalyst. In its denial letter, Cigna offered the following “clinical basis” for denial: Based upon the available information, your symptoms do not meet the Cigna Behavioral Medical Necessity Criteria for Residential Mental Health Treatment for Children and Adolescents for admission and continued stay from 01/06/2020 forward, as you are not reported to be voicing thoughts of harm to self or others. You are not reported to be exhibiting aggressive behavior or disordered thinking. There is no co-occurring severe functional impairment requiring 24-hour supervision. You are medically stable. You have a supportive family. Less restrictive levels of care are available to assist you to learn healthy coping skills, and for medication management. AR 714. Cigna further informed E.F. of his right “to receive free of charge, copies of all documents, records and other information relevant to [an] appeal” of the benefits denial. AR 717. E.F.’s parents appealed the denial. As part of their appeal, E.F.’s parents provided Cigna with five letters from medical professionals who had treated E.F. and an educational consultant who placed E.F. at Open Sky and Catalyst to demonstrate that E.F.’s treatment at Catalyst was medically necessary. See AR 722–23, 755–60, 768–69, 826–30.

Free access — add to your briefcase to read the full text and ask questions with AI

F. v. Cigna Health and Life Insurance, (D. Utah 2025).

F. v. Cigna Health and Life Insurance (F. v. Cigna Health and Life Insurance) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Firestone Tire & Rubber Co. v. Bruch
489 U.S. 101 (Supreme Court, 1989)
Metropolitan Life Insurance v. Glenn
554 U.S. 105 (Supreme Court, 2008)
Kellogg v. Metropolitan Life Insurance
549 F.3d 818 (Tenth Circuit, 2008)
Peterson v. Sun Life Assurance Company
474 F. App'x 725 (Tenth Circuit, 2012)
Keyes-Zachary v. Astrue
695 F.3d 1156 (Tenth Circuit, 2012)
W. v. Health Net Life Insurance Company
86 F.4th 1265 (Tenth Circuit, 2023)
C. v. United Healthcare Insurance Company
87 F.4th 1207 (Tenth Circuit, 2023)